The 15-Day Clock: Common Mistakes in Serious Adverse Reaction Reporting and How Australian Sponsors Can Avoid Them
The 15-day reporting requirement may appear straightforward, but maintaining compliance requires more than simply submitting serious adverse reaction reports to the TGA within a specified timeframe.
Sponsors must understand when Day 0 starts, ensure that safety information is promptly escalated from all relevant sources, apply the correct seriousness criteria and maintain oversight of initial and follow-up submissions.
For smaller Australian medicine sponsors, particularly those marketing complementary and listed medicines, these processes do not need to be unnecessarily complicated. However, they must be clearly defined, consistently implemented and supported by appropriate training and documentation.
Ultimately, the 15-day clock starts when the sponsor first receives the required information, not when someone in the PV department opens the email.
In pharmacovigilance, a delay in communication can quickly become a regulatory compliance issue.